How Does HOPE-3 Change Thinking About Primary Prevention?

–The study lends strong support for statins but delivers a mixed message for antihypertensives. The widely reported results of HOPE-3 may bolster the case for primary prevention with statins and blood pressure drugs. But the trial also makes clear that the benefits, though real, are also modest, and may not be evenly distributed between statins...Click here to continue reading...
Source: CardioBrief - Category: Cardiology Authors: Tags: Policy & Ethics Prevention, Epidemiology & Outcomes antihypertensives blood pressure HOPE-3 primary prevention Rosuvastatin SPRINT statins Source Type: blogs